Mahley R W, Innerarity T L, Weisgraber K B, Oh S Y
J Clin Invest. 1979 Sep;64(3):743-50. doi: 10.1172/JCI109518.
Chemical modification of lysine residues by acetoacetylation of the apoproteins of iodinated canine and human low density lipoproteins (LDL) and canine high density lipoproteins (HDL) resulted in a marked acceleration in the rate of removal of these lipoproteins from the plasma after intravenous injection into dogs. Clearance of the lipoproteins from the plasma correlated with their rapid appearance in the liver. Acetoacetylated canine (125)I-LDL (30-60% of the lysine residues modified) were essentially completely removed from the plasma within an hour, and > 75% of the activity cleared within 5 min. Reversal of the acetoacetylation of the lysine residues of the LDL restored to these lipoproteins a rate of clearance essentially identical to that of control LDL. Identical results were obtained with modified human LDL injected into dogs. At 10 min, when congruent with 90% of the acetoacetylated human (125)I-LDL had been removed from the plasma, 90% of the total injected activity could be accounted for in the liver. Furthermore, it was possible to demonstrate an enhancement in uptake and degradation of acetoacetylated LDL by canine peritoneal macrophages in vitro. The mechanism(s) responsible for the enhanced removal of the LDL and HDL in vivo and in vitro remains to be determined. By contrast, however, acetoacetylation of canine (125)I-apoE HDL(c) did not accelerate their rate of removal from the plasma but, in fact, retarded their clearance. Control (native) apoE HDL(c) were removed from the plasma (64% within 20 min) and rapidly appeared in the liver (39% at 20 min). At the same time point, only 45% of the acetoacetylated apoE HDL(c) were cleared from the plasma and <10% appeared in the liver. Acetoacetylation of the apoE HDL(c) did not enhance their uptake or degradation by macrophages. The rapid clearance from the plasma of the native apoE HDL(c) in normal and hypercholesterolemic dogs suggests that the liver may be a normal site for the removal of the cholesteryl ester-rich apoE HDL(c). The retardation in removal after acetoacetylation of apoE HDL(c) indicates that the uptake process may be mediated by a lysine-dependent recognition system.
通过对碘化犬和人低密度脂蛋白(LDL)以及犬高密度脂蛋白(HDL)的载脂蛋白进行乙酰乙酰化修饰赖氨酸残基,结果显示,将这些脂蛋白静脉注射到犬体内后,其从血浆中的清除速率显著加快。脂蛋白从血浆中的清除与其在肝脏中的快速出现相关。乙酰乙酰化的犬(125)I-LDL(30 - 60%的赖氨酸残基被修饰)在一小时内基本上从血浆中完全清除,且>75%的活性在5分钟内被清除。LDL赖氨酸残基的乙酰乙酰化作用逆转后,这些脂蛋白的清除速率恢复到与对照LDL基本相同的水平。将修饰后的人LDL注射到犬体内也得到了相同的结果。在10分钟时,当90%的乙酰乙酰化人(125)I-LDL已从血浆中清除时,肝脏中可检测到90%的总注射活性。此外,体外实验表明犬腹膜巨噬细胞对乙酰乙酰化LDL的摄取和降解有所增强。体内和体外LDL及HDL清除增强的机制仍有待确定。然而,相比之下,犬(125)I-载脂蛋白E HDL(c)的乙酰乙酰化并没有加快其从血浆中的清除速率,实际上反而延缓了其清除。对照(天然)载脂蛋白E HDL(c)从血浆中清除(20分钟内清除64%)并迅速出现在肝脏中(20分钟时出现39%)。在同一时间点,只有45%的乙酰乙酰化载脂蛋白E HDL(c)从血浆中清除,且<10%出现在肝脏中。载脂蛋白E HDL(c)的乙酰乙酰化并没有增强巨噬细胞对其的摄取或降解。正常和高胆固醇血症犬体内天然载脂蛋白E HDL(c)从血浆中的快速清除表明,肝脏可能是富含胆固醇酯的载脂蛋白E HDL(c)清除的正常部位。载脂蛋白E HDL(c)乙酰乙酰化后清除延缓表明摄取过程可能由依赖赖氨酸的识别系统介导。